Unlike cervical cancer, endometrial cancer often presents with symptoms at an early stage, per the Mayo Clinic, resulting in ...

Endometrial cancer risk is rising, especially among premenopausal women, with diet and lifestyle factors playing a central ...

Endometrial cancer usually returns within three years after treatment. Most of the studies that looked at recurrence rates lasted less than five years, so it's hard to know exactly how many ...

Endometrial cancer is a disease in which cancerous cells form in the tissues of the endometrium, which is part of the uterus. Huntsman Cancer Institute’s Gynecologic Cancers Program provides ...

GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The DESTINY-Endometrial01 study aims to evaluate the ...

Understanding Obesity and Endometrial Cancer Risk: Opportunities for Prevention Schmandt RE, Iglesias DA, Co NN, Lu KH Am J Obstet Gynecol. 2011;205:518-525 ...

That’s a disturbing development, especially in light of the fact that endometrial cancer is the most common gynecologic cancer in the U.S., with some 69,000 new cases and 14,000 deaths estimated ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...